RX2-27395-60867
2 vaccinations
1 coded response
26 check-ins
1 free-text entry
1 call case
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 721 / AR
- Registered
- 2022-07-13
- Relationship
- Child or adolescent in my care
- Guardian
- EBK-25028-00795
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-07-13
Registered in v-safe
-
2022-07-13
Dose 1 — Moderna
- 2022-07-13
- 2022-07-14
- 2022-07-15
- 2022-07-16
- 2022-07-17
- 2022-07-18
- 2022-07-19
- 2022-07-20
- 2022-07-27
- 2022-08-03
- 2022-08-10
-
2022-08-16
Dose 2 — Moderna
- 2022-08-16
-
2022-08-17
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Fair · Site: Redness, Swelling/hardness · Fever · Sleepiness, Irritability/cryingUnder 3 check-in
-
2022-08-18
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Good · Site: Redness, Swelling/hardness · NoneUnder 3 check-in
-
2022-08-19
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Good · Site: Pain, Redness, Swelling/hardness · NoneUnder 3 check-in
-
2022-08-20
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Good · Site: Redness, Swelling/hardness · NoneUnder 3 check-in
- 2022-08-21
- 2022-08-22
- 2022-08-23
- 2022-08-30
- 2022-09-07
- 2022-09-13
- 2022-09-20
- 2022-09-27
-
2022-11-15
Survey response — 3 months, dose 2, under 3MedDRA: Cough — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: CoughMedDRA releases: 2024-11 · check-in free text available
-
2022-11-15
Report sent to call center — 3 months, dose 2, under 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-11-16
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2023-02-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-07-13 | Moderna | No |
| 2 | 2022-08-16 | Moderna | No |
Call center
1 call center case
1 successful
Free text
Release 12 (Under 3) — 3 months, dose 2, under 3
Symptoms: Cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release